UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This intro points to index funds with the highest Sharpe ratios, helping you spot leaders in risk-adjusted return efficiency.
27,038 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
Revolut has begun launching its UK bank after a regulator lifted license restrictions. The phased migration will roll...
Horizon Technology Finance slashes its monthly distribution to $0.06 per share, triggering a sharp stock selloff as f...
Retail investors on Reddit have shifted to a cautious stance on Tesla as late-2025 results reveal delivery declines a...
A federal judge blocked DOJ subpoenas aimed at Fed Chair Powell over a congressional hearing on the central bank’s HQ...
Ripple climbs about 5% to roughly $1.49, but analysts remain wary of a looming sell wall that could cap further gains.
Remaining defendants in the Roberts sexual assault lawsuit have filed motions to dismiss, pushing back against claims...
Three wall street giants are signaling a path for Nvidia to reach $300 by year-end 2026, anchored in accelerating ent...
Lumentum shares jumped about 12% on a $2 billion NVIDIA partnership, as AI data-center buildout and robust backlog un...
Fraudsters used Nigel Farage cameo videos to push unregulated crypto tokens, sparking rapid price spikes and steep de...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...